These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13994665)

  • 1. [Use of preserved blood in extracorporeal circulation].
    TUCCI G; TOMAI F; MARINO B
    Minerva Cardioangiol; 1963 Apr; 11():220-2. PubMed ID: 13994665
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of stored acid-citrate-dextrose (ACD) blood for clinical extracorporeal circulation.
    FOOTE AV; TREDE M; MALONEY JV
    Surg Forum; 1960; 11():230-1. PubMed ID: 13700666
    [No Abstract]   [Full Text] [Related]  

  • 3. An experimental and clinical study of the use of acid-citrate-dextrose (ACD) blood for extracorporeal circulation.
    FOOTE AV; TREDE M; MALONEY JV
    J Thorac Cardiovasc Surg; 1961 Jul; 42():93-109. PubMed ID: 13700665
    [No Abstract]   [Full Text] [Related]  

  • 4. [CONTRIBUTION TO THE USE OF ACD PRESERVED BLOOD IN EXTRACORPOREAL CIRCULATION].
    SMKOVICOVA M; SILVAYOVA O; SIMKOVIC I; SILVAY J
    Bratisl Lek Listy; 1964 Oct; 44():391-7. PubMed ID: 14223727
    [No Abstract]   [Full Text] [Related]  

  • 5. [USE OF CITRATED PRESERVED BLOOD IN EXTRACORPOREAL CIRCULATION].
    BILA K; VACL J; MUSIL J; PRINC M
    Cas Lek Cesk; 1964 Oct; 103():1143-7. PubMed ID: 14206287
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of glycerolized frozen blood in vascular surgery and extracorporeal circulation.
    O'BRIEN TG; HAYNES LL; HERING AC; TULLIS JL; WATKINS E
    Surgery; 1961 Jan; 49():109-29. PubMed ID: 13730022
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE IMPORTANCE OF QUANTITATIVE NEUTRALIZATION OF PRESERVED BLOOD WITH BUFFER SOLUTION IN TRANSFUSIONS AND IN EXTRACORPOREAL CIRCULATION].
    SOMMERKAMP H
    Thoraxchir Vask Chir (1962); 1965 Jun; 13():81-8. PubMed ID: 14305838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Edglugate-Mg blood preservation agent for use in extracorporeal circulation. Restrictions to be observed in its use].
    LAURENT D; SPROVIERI L; PRIGENT C; JAULMES B
    Presse Med (1893); 1962 Feb; 70():371-3. PubMed ID: 14462838
    [No Abstract]   [Full Text] [Related]  

  • 9. The conservation of blood to be used in extracorporeal circulation.
    WINTERSTEIN A; STUDER A
    Bibl Haematol; 1962; 13():92-4. PubMed ID: 14007621
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical evaluation of fresh and stored heparinized blood for use in extracorporeal circulation.
    LOBPREIS EL; RASCHKE E; WATANABE Y; MALONEY JV
    Ann Surg; 1960 Dec; 152(6):947-53. PubMed ID: 13762957
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON SERUM LIPID CHANGES AND THE APPEARANCE OF FREE FAT DROPS IN EXTRACORPOREAL CIRCULATION].
    KASPAR F
    Thoraxchir Vask Chir (1962); 1965 Feb; 12():481-6. PubMed ID: 14273982
    [No Abstract]   [Full Text] [Related]  

  • 12. The acid-base status of donor blood as used for extracorporeal circulation.
    GUTELIUS JR; DOBELL AR
    Can J Surg; 1960 Jan; 3():130-3. PubMed ID: 13830436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ed-Glu-Gate solution for the taking of blood to be used in extracorporeal circulation].
    JAULMES B; PRIGENT C; SPROVIERI L; LAURENT D; TERRIER E
    Pathol Biol; 1961 Oct; 9():1873-86. PubMed ID: 14451429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extracorporal circulation with ACD-preserved blood--with special reference to acid-base balance].
    Saigusa M; Mizuno A; Morimoto K; Ninomiya K; Yoshitake T
    Kyobu Geka; 1966 Nov; 19(11):757-65. PubMed ID: 6009739
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study and recommendation of preserved blood to be used for total extracorporeal perfusion, with special reference to EDTA].
    Gál G; Eck E; Kovács G; Maráz A; Boda D
    Orv Hetil; 1975 Dec; 116(52):3052-5. PubMed ID: 812036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the blood caused by the materials used in extracorporeal circulation].
    FRIE PC
    Helv Physiol Pharmacol Acta; 1960; 18():447-63. PubMed ID: 13701913
    [No Abstract]   [Full Text] [Related]  

  • 17. [On control of hemolysis in preserved blood by stabilizer supplements].
    MEYER-WEGENER H
    Thoraxchirurgie; 1961 Oct; 9():367-8. PubMed ID: 14473186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of some methods of measurement of hemolysis and its use with preserved blood].
    FREI PC; FLEISCH H
    Acta Haematol; 1962; 27():47-53. PubMed ID: 13894953
    [No Abstract]   [Full Text] [Related]  

  • 19. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
    Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Certain blood changes in patients undergoing extracorporeal circulation; analysis of 350 perfusions.
    DEWALL RA; LONG DM; GEMMILL SJ; LILLEHEI CW
    J Thorac Surg; 1959 Mar; 37(3):325-33. PubMed ID: 13631723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.